Endotype-driven precision medicine in chronic rhinosinusitis
- 22 October 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 15 (11) , 1171-1183
Abstract
Introduction: Chronic rhinosinusitis (CRS) is a heterogeneous disease spectrum with variable phenotypes and endotypes that are not well characterized. Conventional treatment options are insufficient; recent research in precision medicine focuses on providing endotype-driven care based on underlying mechanisms. Areas covered: A comprehensive overview of CRS phenotypes and endotypes is provided. Biomarkers have been identified to predict prognosis and guide personalized pharmacotherapy, surgery, and innovative treatments. For CRS with nasal polyps (CRSwNP), type 2-targeting biologics, such as anti-IgE, anti-IL4Rα, and anti-IL5 antibodies, have been explored in clinical trials. Expert opinion: In addition to differences in immunopathogenic mechanisms and responses to medical and surgical interventions, CRS endotypes vary according to geography and ethnicity and their distributions change over time. Endotype-driven integrated care is a promising approach. Our current understanding of type 2 inflammation is well ahead of that of other endotypes. Biomarkers of type 2 inflammation show good predictive ability for corticosteroid responsiveness and disease recurrence. Type 2-targeted treatments are effective for CRSwNP based on clinical trials. The identification of patient subsets and effective biomarkers is important for optimizing biotherapeutic strategies. Further studies should focus on non-type 2 inflammation-targeted treatment approaches and the safety of biologics for routine clinical use.Keywords
This publication has 126 references indexed in Scilit:
- High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effectsJournal of Allergy and Clinical Immunology, 2013
- Changes in Histological Features of Nasal Polyps in a Korean Population over a 17‐year PeriodOtolaryngology–Head and Neck Surgery, 2013
- Decreased SPLUNC1 expression is associated with pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgeryThe Laryngoscope, 2013
- Identification of Chronic Rhinosinusitis Phenotypes Using Cluster AnalysisAmerican Journal of Rhinology & Allergy, 2012
- Structured histopathology profiling of chronic rhinosinusitis in routine practiceInternational Forum of Allergy & Rhinology, 2012
- Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adultsThe Laryngoscope, 2012
- Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroidsInternal Medicine Journal, 2011
- An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiationInternational Immunology, 2011
- Long‐term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitisThe Laryngoscope, 2009
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophilsJournal of Allergy and Clinical Immunology, 2004